Rechercher | Social.So

Social.So

Rutuja Deshmukh Ajouter une nouvelle offre d'emploi Autre
2026-06-23 11:03:58 -

Keytruda Market Forecast Based on Growing Demand for Cancer Immunotherapy
The global Keytruda Market was valued at USD 31.4 billion in 2025 and is projected to grow from USD 32.7 billion in 2026 to USD 25.0 billion by 2033, registering a CAGR of -3.8% from 2026 to 2033. While Keytruda (pembrolizumab) remains one of the most successful immunotherapy drugs globally, the market is expected to face headwinds over the forecast period due to patent expiration,...

0 Commentaires 0 Parts 625 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Nayana Mane Ajouter une nouvelle offre d'emploi Networking
2026-07-14 17:16:07 -

Keytruda Market: Oncology Innovation & Forecast 2024–2034
Market Scope The Keytruda Market is witnessing significant growth as immunotherapy continues to transform modern cancer treatment. Keytruda (pembrolizumab), developed by Merck & Co., Inc., is one of the world's leading immune checkpoint inhibitors targeting the PD-1 pathway. It has become a preferred treatment option for a wide range of cancers, including non-small cell lung...

0 Commentaires 0 Parts 320 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!